CSIA
PFE icon

Charles Schwab Investment Advisory’s Pfizer PFE Stock Holding History

Charles Schwab Investment Advisory’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,155,201
Closed -$338M – 176
2018
Q4 		$338M Sell
8,155,201
-157,725
-2% -$6.55M 0.64% 40
2018
Q3 		$348M Sell
8,312,926
-2,527
-0% -$97.3K 0.6% 44
2018
Q2 		$286M Buy
+8,315,453
New +$284M 0.52% 53

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab Investment Advisory's PFE Position: Q1 2019 in Review

Charles Schwab Investment Advisory sold out of Pfizer (PFE) in Q1 2019, closing a stake of 8,155,201 shares — an estimated $338M sold.

Charles Schwab Investment Advisory first reported a position in PFE in Q2 2018 and held it in 3 quarters. The position peaked at $348M in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Charles Schwab Investment Advisory reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
  • Charles Schwab Investment Advisory sold 8,155,201 Pfizer shares in Q1 2019, an estimated $338M.
  • Charles Schwab Investment Advisory first reported a position in Pfizer in Q2 2018 and held it in 3 quarters.
  • Charles Schwab Investment Advisory's Pfizer position peaked at $348M in Q3 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Charles Schwab Investment Advisory's 13F filing for Q1 2019, filed 14 May 2019.